Object detection: A novel AI technology for the diagnosis of hepatocyte ballooning.

Journal: Liver international : official journal of the International Association for the Study of the Liver
PMID:

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) has reached epidemic proportions worldwide and is the most frequent cause of chronic liver disease in developed countries. Within the spectrum of liver disease in MAFLD, steatohepatitis is a progressive form of liver disease and hepatocyte ballooning (HB) is a cardinal pathological feature of steatohepatitis. The accurate and reproducible diagnosis of HB is therefore critical for the early detection and treatment of steatohepatitis. Currently, a diagnosis of HB relies on pathological examination by expert pathologists, which may be a time-consuming and subjective process. Hence, there has been interest in developing automated methods for diagnosing HB. This narrative review briefly discusses the development of artificial intelligence (AI) technology for diagnosing fatty liver disease pathology over the last 30 years and provides an overview of the current research status of AI algorithms for the identification of HB, including published articles on traditional machine learning algorithms and deep learning algorithms. This narrative review also provides a summary of object detection algorithms, including the principles, historical developments, and applications in the medical image analysis. The potential benefits of object detection algorithms for HB diagnosis (specifically those combined with a transformer architecture) are discussed, along with the future directions of object detection algorithms in HB diagnosis and the potential applications of generative AI on transformer architecture in this field. In conclusion, object detection algorithms have huge potential for the identification of HB and could make the diagnosis of MAFLD more accurate and efficient in the near future.

Authors

  • Tian-Lei Zheng
    School of Information and Control Engineering, China University of Mining and Technology, Xuzhou, China.
  • Jun-Cheng Sha
    Department of Interventional Radiology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Qian Deng
    Eye Center, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
  • Shi Geng
    Artificial Intelligence Unit, Department of Medical Equipment Management, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221004, China.
  • Shu-Yuan Xiao
    Department of Pathology, University of Chicago Medicine, Chicago, Illinois, USA.
  • Wen-Jun Yang
    Department of Pathology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou, China.
  • Christopher D Byrne
    Southampton National Institute for Health and Care Research Biomedical Research Centre, University Hospital Southampton and University of Southampton, Southampton General Hospital, Southampton, UK.
  • Giovanni Targher
    Department of Medicine, University of Verona, Verona, Italy.
  • Yang-Yang Li
    Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Xiang-Xue Wang
    Institute for AI in Medicine, School of Artificial Intelligence, Nanjing University of Information Science and Technology, Nanjing, China.
  • Di Wu
    University of Melbourne, Melbourne, VIC 3010 Australia.
  • Ming-Hua Zheng
    MAFLD Research Center, Department of Hepatology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.